Chromatin mechanisms regulating gene expression in health and disease

Advances in Experimental Medicine and Biology

Volumn 711, Issue , 2011, Pages 12-25

  Bonifer, Constanze ^a   Cockerill, Peter N ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROCHROMATIN PROTEIN 1; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H2A; HISTONE H2B; HISTONE METHYLTRANSFERASE; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR T BET; TRANSCRIPTION FACTOR;

ARTICLE; AUTOIMMUNITY; BINDING SITE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; CHROMATIN STRUCTURE; CPG ISLAND; DEACETYLATION; DNA METHYLATION; ENHANCER REGION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; HUMAN; INFLAMMATION; ISOMERIZATION; LEUKEMIA; MEMORY T LYMPHOCYTE; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; GENETIC EPIGENESIS; GENETICS; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

ANIMALS; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA; NUCLEOSOMES; TRANSCRIPTION FACTORS;

EID: 79958279954     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-8216-2_2     Document Type: Article

References (88)

1. de Laat W, Klous P, Kooren J et al. Three-dimensional organization of gene expression in erythroid cells. Curr Top Dev Biol 2008; 82:117-139.
2. Gialitakis M, Arampatzi P, Makatounakis T et al. Interferon gamma dependent transcriptional memory via relocalization of a gene locus to PML nuclear bodies. Mol Cell Biol 2010; 30(8):2046-2056.
3. Mirabella F, Baxter EW, Boissinot M et al. The Human IL-3/Granulocyte- Macrophage Colony-Stimulating Factor Locus Is Epigenetically Silent in Immature Thymocytes and Is Progressively Activated during T-Cell Development. J Immunol 2010; 184(6):3043-3054.
4. Chen MJ, Yokomizo T, Zeigler BM et al. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature 2009; 457(7231):887-891.
5. Hoogenkamp M, Lichtinger M, Krysinska H et al. Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. Blood 2009; 114(2):299-309.
6. Zlatanova J, Leuba SH, van Holde K. Chromatin structure revisited. Crit Rev Eukaryot Gene Expr 1999; 9(3-4):245-255. (Pubitemid 30053877)
7. Luger K, Mader AW, Richmond RK et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389(6648):251-260. (Pubitemid 27406632)
8. Robinson PJ, Fairall L, Huynh VA et al. EM measurements define the dimensions ofthe "30-nm" chromatin fiber: evidence for a compact, interdigitated structure. Proc Natl Acad Sci USA 2006; 103(17):6506-6511.
9. Schalch T, Duda S, Sargent DF et al. X-ray structure of a tetranucleosome and its implications for the chromatin fibre. Nature 2005; 436(7047):138-141. (Pubitemid 40966200)
10. Williams SP, Athey BD, Muglia LJ et al. Chromatin fibers are left-handed double helices with diameter and mass per unit length that depend on linker length. Biophys J 1986; 49(1):233-248. (Pubitemid 16155467)
11. Woodcock CL, Frado LL, Rattner JB. The higher-order structure of chromatin: evidence for a helical ribbon arrangement. J Cell Biol 1984; 99(1 Pt 1):42-52. (Pubitemid 14096865)
12. Hu Y, Kireev I, Plutz M et al. Large-scale chromatin structure of inducible genes: transcription on a condensed, linear template. J Cell Biol 2009; 185(1):87-100.
13. Gross DS, Garrard WT. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem 1988; 57:159-197.
14. Carrozza MJ, Li B, Florens L et al. Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell 2005; 123(4):581-592. (Pubitemid 41608462)
15. Zippo A, Seraffni R, Rocchigiani M et al. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 2009; 138(6):1122-1136.
16. Kouzarides T. Chromatinmodifications andtheir function. Cell 2007; 128(4):693-705.
17. Shogren-Knaak M, Ishii H, Sun JM et al. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006; 311(5762):844-847. (Pubitemid 43228847)
18. Jin C, Felsenfeld G. Nucleosome stability mediated by histone variants H3.3 and H2A.Z. Genes Dev 2007; 21(12):1519-1529. (Pubitemid 46955724)
19. Enver T, Greaves M. Loops, lineage and leukemia. Cell 1998; 94(1):9-12.
20. Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009; 10(3):192-206.
21. Berger SL, Kouzarides T, Shiekhattar R et al. An operational definition of epigenetics. Genes Dev 2009; 23(7):781-783.
22. Bird A. DNAmethylation patterns and epigenetic memory. Genes Dev 2002; 16(1):6-21.
23. Berger J, Bird A. Role of MBD2 in gene regulation and tumorigenesis. Biochem Soc Trans 2005; 33(Pt 6):1537-1540. (Pubitemid 41779733)
24. Bird A. The methyl-CpG-binding protein MeCP2 and neurological disease. Biochem Soc Trans 2008; 36(Pt 4):575-583.
25. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10(5):295-304.
26. Chen T, Li E. Establishment and maintenance of DNA methylation patterns in mammals. Curr Top Microbiol Immunol 2006; 301:179-201. (Pubitemid 43022672)
27. Ooi SK, Qiu C, Bernstein E et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007; 448(7154):714-717. (Pubitemid 47236857)
28. Jia D, Jurkowska RZ, Zhang X et al. Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature 2007; 449(7159):248-251. (Pubitemid 47402375)
29. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010; 31(1):27-36.
30. Boultwood J, Wainscoat JS. Gene silencing by DNA methylation in haematological malignancies. Br J Haematol 2007; 138(1):3-11. (Pubitemid 46889779)
31. Fandy TE. Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases. Curr Med Chem 2009; 16(17):2075-2085.
32. Gebhard C, Benner C, Ehrich M et al. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Cancer Res 70(4):1398-1407.
33. Zhu JK. Active DNA demethylation mediated by DNA glycosylases. Annu Rev Genet 2009; 43:143-166.
34. Thomson JP, Skene PJ, Selfridge J et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010; 464(7291):1082-1086.
35. Ansari KI, Mishra BP, Mandal SS. Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. Biochim Biophys Acta 2008; 1779(1):66-73.
36. Tate CM, Lee JH, Skalnik DG. CXXC finger protein 1 restricts the SetdlA histone H3K4 methyltransferase complex to euchromatin. FEBS J 2010; 277(1):210-223.
37. Shilatifard A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation.Curr Opin Cell Biol 2008; 20(3):341-348.
38. Tahiliani M, Koh KP, Shen Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324(5929):930-935.
39. Loenarz C, Schofield CJ. Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem Biol 2009; 16(6):580-583.
40. Allen MD, Grummitt CG, Hilcenko C et al. Solution structure of the nonmethyl-CpG-binding CXXC domain of the leukaemia-associated MLL histone methyltransferase. EMBO J 2006; 25(19):4503-4512. (Pubitemid 44498124)
41. Carlone DL, LeeJH, Young SR et al. Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein. Mol Cell Biol 2005; 25(12):4881-4891. (Pubitemid 40781090)
42. Mullighan CG. TET2 mutations in myelodysplasia and myeloid malignancies. Nat Genet 2009; 41(7):766-767.
43. Abdel-Wahab O, Mullally A, Hedvat C et al. Genetic characterization of TET1, TET2 and TET3 alterations in myeloid malignancies. Blood 2009; 114(1):144-147.
44. Jankowska AM, Szpurka H, Tiu RV et al. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 2009; 113(25):6403-6410.
45. Ono R, Taki T, Taketani T et al. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 2002; 62(14):4075-4080. (Pubitemid 34791077)
46. Jenuwein T, Allis CD. Translating the histone code. Science 2001; 293(5532):1074-1080. (Pubitemid 32758077)
47. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31(2):89-97. (Pubitemid 43221841)
48. Lachner M, O'Carroll D, Rea S et al. Methylation ofhistoneH3 lysine 9 creates a binding site for HP1 proteins. Nature 2001; 410(6824):116-120. (Pubitemid 32225847)
49. Bannister AJ, Zegerman P, Partridge JF et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410(6824):120-124. (Pubitemid 32225848)
50. Esteve PO, Chin HG, Smallwood A et al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 2006; 20(22):3089-3103. (Pubitemid 44790625)
51. Smallwood A, Esteve PO, Pradhan S et al. Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 2007; 21(10):1169-1178. (Pubitemid 46789875)
52. Nan X, Ng HH, Johnson CA et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998; 393(6683):386-389. (Pubitemid 28269714)
53. Metivier R, Penot G, Hubner MR et al. Estrogen receptor-alpha directs ordered, cyclical and combinatorial recruitment of cofactors on a natural target promoter. Cell 2003; 115(6):751-763. (Pubitemid 38030303)
54. Schlesinger Y, Straussman R, Keshet I et al. Polycomb-mediated methylation on Lys27 ofhistone H3 premarks genes for de novo methylation in cancer. Nat Genet 2007; 39(2):232-236. (Pubitemid 46184355)
55. Ohm JE, McGarvey KM, Yu X et al. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 2007; 39(2):237-242. (Pubitemid 46184356)
56. Wang Z, Zang C, Rosenfeld JA et al. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40(7):897-903. (Pubitemid 351913645)
57. Wang Z, Zang C, Cui K et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009; 138(5):1019-1031.
58. Ghisletti S, Barozzi I, Mietton F et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity.
59. Cirillo LA, Lin FR, Cuesta I et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Molecular Cell 2002; 9(2):279-289. (Pubitemid 34195554)
60. Cockerill PN. NFAT is well placed to direct both enhancer looping and domain-wide models of enhancer function. Sci Signal 2008; 1(13):pe15.
61. Hogan PG, Chen L, Nardone J et al. Transcriptional regulation by calcium, calcineurin and NFAT. Genes Dev 2003; 17(18):2205-2232. (Pubitemid 37128637)
62. Mellor J. Dynamic nucleosomes and gene transcription. Trends Genet 2006; 22(6):320-329. (Pubitemid 43794925)
63. Shahbazian MD, Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem 2007; 76:75-100.
64. Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447(7143):407-412. (Pubitemid 46816746)
65. Li B, Carey M, Workman JL. The role of chromatin during transcription. Cell 2007; 128(4):707-719. (Pubitemid 46273570)
66. Johnson BV, Bert AG, Ryan GR et al. GM-CSF enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol Cell Biol 2004; 24(18):7914-7930. (Pubitemid 39167442)
67. Bert AG, Johnson BV, Baxter EW et al. A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling. Mol Cell Biol 2007; 27(8):2870-2885. (Pubitemid 46581303)
68. Lefevre P, Witham J,Lacroix CE et al. The LPS-inducedtranscriptional upregulation ofthe chicken lysozymelocus involves CTCF eviction and noncoding RNA transcription. Mol Cell 2008; 32(1):129-139.
69. Hassan AH, Prochasson P, Neely KE et al. Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 2002; 111(3):369-379. (Pubitemid 35345152)
70. Marmorstein R, Berger SL. Structure and function of bromodomains in chromatin-regulating complexes. Gene 2001; 272(1-2): 1-9. (Pubitemid 32695392)
71. Vermeulen M, Mulder KW, Denissov S et al. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 2007; 131(1):58-69. (Pubitemid 47498531)
72. Muramoto T, Muller I, Thomas G et al. Methylation ofH3K4 Is Required for Inheritance of Active Transcriptional States. Curr Biol 20(5):397-406.
73. Wang GG, Song J, Wang Z et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009; 459(7248):847-851.
74. Bowen DT. Chronic myelomonocytic leukemia: lost in classification? Hematol Oncol 2005; 23(1):26-33. (Pubitemid 41595187)
75. Russell NH. Autocrine growth factors and leukaemic haemopoiesis. Blood Rev 1992; 6(3):149-156.
76. Birnbaum RA, O'Marcaigh A, Wardak Z et al. Nf1 and Gmcsf interact in myeloid leukemogenesis. Mol Cell 2000; 5(1):189-195. (Pubitemid 30105448)
77. Parikh C, Subrahmanyam R, Ren R. Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice. Blood 2006; 108(7):2349-2357. (Pubitemid 44497519)
78. Ramshaw HS, Bardy PG, Lee MA et al. Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo. Exp Hematol 2002; 30(10):1124-1131.
79. Van Waes C. Nuclear factor-kappaB in development, prevention and therapy of cancer. Clin Cancer Res 2007; 13(4):1076-1082. (Pubitemid 46424045)
80. Bargou RC, Emmerich F, Krappmann D et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997; 100(12):2961-2969. (Pubitemid 28022832)
81. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer 2009; 9(1):15-27.
82. Mathas S, Janz M, Hummel F et al. Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 2006; 7(2):207-215. (Pubitemid 43135887)
83. Bonifer C, Hume DA. The transcriptional regulation of the Colony-Stimulating Factor 1 Receptor (csf1r) gene during hematopoiesis. Front Biosci 2008; 13:549-560. (Pubitemid 351599765)
84. Lamprecht B, Walter K, Kreher S et al. De-repression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nature Medicine 2010; 16(5):571-579.
85. Szyf M. Epigenetic therapeutics in autoimmune disease. Clin Rev Allergy Immunol 2009.
86. Zhou Y, Lu Q. DNA methylation in T-cells from idiopathic lupus and drug-induced lupus patients. Autoimmun Rev 2008; 7(5):376-383.
87. Richardson B. DNA methylation and autoimmune disease. Clin Immunol 2003; 109(1):72-79. (Pubitemid 37324744)
88. Mi XB, Zeng FQ. Hypomethylation of interleukin-4 and -6 promoters in T-cells from systemic lupus erythematosus patients. Acta Pharmacol Sin 2008; 29(1):105-112.